Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Common Equity (2018 - 2025)

Nexgel (NXGL) has disclosed Common Equity for 8 consecutive years, with $5.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity rose 11.83% year-over-year to $5.6 million, compared with a TTM value of $5.6 million through Sep 2025, up 11.83%, and an annual FY2024 reading of $5.8 million, up 11.4% over the prior year.
  • Common Equity was $5.6 million for Q3 2025 at Nexgel, up from $5.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $12.1 million in Q4 2021 and bottomed at $270000.0 in Q2 2021.
  • Average Common Equity over 5 years is $5.9 million, with a median of $5.6 million recorded in 2025.
  • Peak annual rise in Common Equity hit 16921.13% in 2021, while the deepest fall reached 38.78% in 2021.
  • Year by year, Common Equity stood at $12.1 million in 2021, then tumbled by 36.81% to $7.6 million in 2022, then tumbled by 32.36% to $5.2 million in 2023, then rose by 11.4% to $5.8 million in 2024, then fell by 3.11% to $5.6 million in 2025.
  • Business Quant data shows Common Equity for NXGL at $5.6 million in Q3 2025, $5.1 million in Q2 2025, and $5.6 million in Q1 2025.